Cassava Sciences, Inc. (SAVA)
USD 1.26
(-1.18%)
USD 1.26
(-1.18%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -121.13 Million USD | 39.7% |
| 2022 | -200.87 Million USD | 13.86% |
| 2021 | -233.2 Million USD | -150.18% |
| 2020 | -93.21 Million USD | -305.43% |
| 2019 | -22.99 Million USD | -16.08% |
| 2018 | -19.8 Million USD | -89.02% |
| 2017 | -10.47 Million USD | 44.0% |
| 2016 | -18.71 Million USD | 40.21% |
| 2015 | -31.29 Million USD | 22.89% |
| 2014 | -40.59 Million USD | 18.56% |
| 2013 | -49.83 Million USD | 11.41% |
| 2012 | -56.25 Million USD | 23.09% |
| 2011 | -73.14 Million USD | -1424.47% |
| 2010 | -4.79 Million USD | 86.6% |
| 2009 | -35.79 Million USD | 76.63% |
| 2008 | -153.15 Million USD | -76.92% |
| 2007 | -86.56 Million USD | -428.3% |
| 2006 | -16.38 Million USD | 82.87% |
| 2005 | -95.65 Million USD | -6836.26% |
| 2004 | -1.37 Million USD | 88.53% |
| 2003 | -12.02 Million USD | 75.99% |
| 2002 | -50.09 Million USD | 23.26% |
| 2001 | -65.27 Million USD | 17.3% |
| 2000 | -78.92 Million USD | -745.07% |
| 1999 | -9.33 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -207.29 Million USD | -66.94% |
| 2024 Q1 | -124.16 Million USD | -2.5% |
| 2023 Q2 | -168.43 Million USD | 10.15% |
| 2023 Q4 | -121.13 Million USD | 14.9% |
| 2023 Q3 | -142.35 Million USD | 15.49% |
| 2023 FY | -121.13 Million USD | 39.7% |
| 2023 Q1 | -187.46 Million USD | 6.68% |
| 2022 Q3 | -174.49 Million USD | 11.44% |
| 2022 Q4 | -200.87 Million USD | -15.12% |
| 2022 FY | -200.87 Million USD | 13.86% |
| 2022 Q1 | -209.48 Million USD | 10.17% |
| 2022 Q2 | -197.04 Million USD | 5.94% |
| 2021 Q1 | -281.89 Million USD | -202.42% |
| 2021 Q2 | -277.97 Million USD | 1.39% |
| 2021 Q4 | -233.2 Million USD | 3.34% |
| 2021 FY | -233.2 Million USD | -150.18% |
| 2021 Q3 | -241.26 Million USD | 13.21% |
| 2020 Q3 | -23.75 Million USD | 5.76% |
| 2020 Q1 | -25.53 Million USD | -11.06% |
| 2020 Q2 | -25.2 Million USD | 1.27% |
| 2020 Q4 | -93.21 Million USD | -292.34% |
| 2020 FY | -93.21 Million USD | -305.43% |
| 2019 Q4 | -22.99 Million USD | -29.96% |
| 2019 Q1 | -18.96 Million USD | 4.24% |
| 2019 FY | -22.99 Million USD | -16.08% |
| 2019 Q3 | -17.69 Million USD | 3.85% |
| 2019 Q2 | -18.39 Million USD | 2.99% |
| 2018 Q3 | -20.44 Million USD | -112.78% |
| 2018 Q4 | -19.8 Million USD | 3.12% |
| 2018 FY | -19.8 Million USD | -89.02% |
| 2018 Q1 | -10.73 Million USD | -2.43% |
| 2018 Q2 | -9.6 Million USD | 10.49% |
| 2017 Q4 | -10.47 Million USD | 12.06% |
| 2017 Q3 | -11.91 Million USD | 15.29% |
| 2017 Q2 | -14.06 Million USD | 18.52% |
| 2017 FY | -10.47 Million USD | 44.0% |
| 2017 Q1 | -17.26 Million USD | 7.75% |
| 2016 Q2 | -24.62 Million USD | 7.47% |
| 2016 Q3 | -21.76 Million USD | 11.62% |
| 2016 Q4 | -18.71 Million USD | 14.01% |
| 2016 Q1 | -26.61 Million USD | 14.97% |
| 2016 FY | -18.71 Million USD | 40.21% |
| 2015 FY | -31.29 Million USD | 22.89% |
| 2015 Q2 | -36.35 Million USD | 7.38% |
| 2015 Q4 | -31.29 Million USD | 7.93% |
| 2015 Q3 | -33.99 Million USD | 6.49% |
| 2015 Q1 | -39.24 Million USD | 3.31% |
| 2014 Q3 | -42.05 Million USD | 6.19% |
| 2014 FY | -40.59 Million USD | 18.56% |
| 2014 Q2 | -44.82 Million USD | 4.83% |
| 2014 Q1 | -47.1 Million USD | 5.49% |
| 2014 Q4 | -40.59 Million USD | 3.48% |
| 2013 Q1 | -51.59 Million USD | 8.29% |
| 2013 FY | -49.83 Million USD | 11.41% |
| 2013 Q2 | -51.54 Million USD | 0.09% |
| 2013 Q4 | -49.83 Million USD | 2.33% |
| 2013 Q3 | -51.02 Million USD | 1.0% |
| 2012 FY | -56.25 Million USD | 23.09% |
| 2012 Q4 | -56.25 Million USD | 36.25% |
| 2012 Q3 | -88.24 Million USD | -11.67% |
| 2012 Q2 | -79.02 Million USD | -7.1% |
| 2012 Q1 | -73.77 Million USD | -0.87% |
| 2011 Q4 | -73.14 Million USD | -2.0% |
| 2011 Q3 | -71.7 Million USD | -14.13% |
| 2011 Q2 | -62.83 Million USD | -14.46% |
| 2011 Q1 | -54.89 Million USD | -1044.1% |
| 2011 FY | -73.14 Million USD | -1424.47% |
| 2010 Q1 | -50.65 Million USD | -41.52% |
| 2010 Q3 | -106.29 Million USD | -59.18% |
| 2010 Q2 | -66.77 Million USD | -31.81% |
| 2010 Q4 | -4.79 Million USD | 95.49% |
| 2010 FY | -4.79 Million USD | 86.6% |
| 2009 Q2 | -145.2 Million USD | 15.97% |
| 2009 Q1 | -172.79 Million USD | -12.82% |
| 2009 Q3 | -29.16 Million USD | 79.91% |
| 2009 Q4 | -35.79 Million USD | -22.71% |
| 2009 FY | -35.79 Million USD | 76.63% |
| 2008 Q1 | -130.8 Million USD | -51.1% |
| 2008 Q4 | -153.15 Million USD | -6.4% |
| 2008 Q3 | -143.95 Million USD | -14.77% |
| 2008 Q2 | -125.42 Million USD | 4.11% |
| 2008 FY | -153.15 Million USD | -76.92% |
| 2007 Q4 | -86.56 Million USD | -112.1% |
| 2007 Q3 | -40.81 Million USD | 17.03% |
| 2007 FY | -86.56 Million USD | -428.3% |
| 2007 Q2 | -49.19 Million USD | 20.42% |
| 2007 Q1 | -61.81 Million USD | -277.25% |
| 2006 FY | -16.38 Million USD | 82.87% |
| 2006 Q4 | -16.38 Million USD | 48.08% |
| 2006 Q3 | -31.55 Million USD | 38.25% |
| 2006 Q2 | -51.1 Million USD | 24.65% |
| 2006 Q1 | -67.82 Million USD | 29.09% |
| 2005 Q3 | -1.42 Million USD | 43.43% |
| 2005 Q1 | -107 Thousand USD | 92.24% |
| 2005 FY | -95.65 Million USD | -6836.26% |
| 2005 Q4 | -95.65 Million USD | -6631.25% |
| 2005 Q2 | -2.51 Million USD | -2247.66% |
| 2004 Q1 | -7.18 Million USD | 40.29% |
| 2004 FY | -1.37 Million USD | 88.53% |
| 2004 Q3 | -1.75 Million USD | 44.83% |
| 2004 Q4 | -1.37 Million USD | 21.2% |
| 2004 Q2 | -3.17 Million USD | 55.83% |
| 2003 Q3 | -46.9 Million USD | -10.23% |
| 2003 Q2 | -42.54 Million USD | 6.83% |
| 2003 Q4 | -12.02 Million USD | 74.36% |
| 2003 Q1 | -45.66 Million USD | 8.84% |
| 2003 FY | -12.02 Million USD | 75.99% |
| 2002 Q4 | -50.09 Million USD | 7.05% |
| 2002 FY | -50.09 Million USD | 23.26% |
| 2002 Q1 | -61.35 Million USD | 6.0% |
| 2002 Q2 | -57.8 Million USD | 5.79% |
| 2002 Q3 | -53.89 Million USD | 6.77% |
| 2001 Q1 | -75.95 Million USD | 3.77% |
| 2001 Q4 | -65.27 Million USD | 4.63% |
| 2001 Q2 | -71.64 Million USD | 5.68% |
| 2001 FY | -65.27 Million USD | 17.3% |
| 2001 Q3 | -68.44 Million USD | 4.47% |
| 2000 Q4 | -78.92 Million USD | 3.74% |
| 2000 Q3 | -81.99 Million USD | -309.56% |
| 2000 Q1 | -22.17 Million USD | 0.0% |
| 2000 FY | -78.92 Million USD | -745.07% |
| 2000 Q2 | -20.02 Million USD | 9.73% |
| 1999 FY | -9.33 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -116.546% |
| Alkermes plc | -166.73 Million USD | 27.35% |
| Agenus Inc. | 274.13 Million USD | 144.188% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 106.478% |
| Aptorum Group Limited | 1.35 Million USD | 9026.448% |
| Ardelyx, Inc. | 34.51 Million USD | 450.997% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 2930.28% |
| Bicycle Therapeutics plc | -481.46 Million USD | 74.84% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 434.972% |
| ChromaDex Corporation | -24.04 Million USD | -403.726% |
| Chimerix, Inc. | -25.51 Million USD | -374.727% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1838.443% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -411.619% |
| CRISPR Therapeutics AG | -150.84 Million USD | 19.695% |
| Precision BioSciences, Inc. | -85.41 Million USD | -41.829% |
| Dyadic International, Inc. | -6.37 Million USD | -1799.249% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -660.284% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1680.378% |
| Lantern Pharma Inc. | -21.7 Million USD | -458.146% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -9.589% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1317.927% |
| Incyte Corporation | -3.17 Billion USD | 96.185% |
| IO Biotech, Inc. | -140.69 Million USD | 13.904% |
| Jaguar Health, Inc. | 29.39 Million USD | 512.153% |
| Novavax, Inc. | -298.29 Million USD | 59.39% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2369.74% |
| Opthea Limited | 28.15 Million USD | 530.209% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -621.52% |
| ContextLogic Inc. | -232 Million USD | 47.786% |
| MiMedx Group, Inc. | -33.9 Million USD | -257.323% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1288.19% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -5128.079% |
| NextCure, Inc. | -6.47 Million USD | -1770.249% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -139.869% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1798.981% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1095.917% |
| Vaxcyte, Inc. | -368.22 Million USD | 67.103% |
| PDS Biotechnology Corporation | -32.7 Million USD | -270.346% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 801.1% |
| Pharming Group N.V. | 109.8 Million USD | 210.32% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -596.344% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 30.87% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -554.087% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -554.087% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1606.141% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -1967.167% |
| Acelyrin, Inc. | -216.9 Million USD | 44.152% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2059.184% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -6926.45% |
| Summit Therapeutics Inc. | 34.67 Million USD | 449.357% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1680.626% |
| Senti Biosciences, Inc. | 1.74 Million USD | 7061.839% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 34.382% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -56.403% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -1898.284% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 121516.472% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 19389.172% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -3.494% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 27.995% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 209.259% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1494.734% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 6.179% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 1856.97% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 50.019% |
| Immix Biopharma, Inc. | -17.5 Million USD | -591.819% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 61.751% |
| MEI Pharma, Inc. | -3.7 Million USD | -3169.528% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1068.236% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 174.895% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 535.851% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1680.378% |
| Precigen, Inc. | -481 Thousand USD | -25084.2% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 960.28% |
| AlloVir, Inc. | -62.69 Million USD | -93.224% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -117.816% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 296.439% |
| ImmuCell Corporation | 10.99 Million USD | 1202.182% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 21.415% |
| Onconetix, Inc. | 5.33 Million USD | 2372.108% |
| PureTech Health plc | -167.19 Million USD | 27.549% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -297.689% |
| Elevation Oncology, Inc. | -19.11 Million USD | -533.623% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2367.631% |
| Seer, Inc. | -4.24 Million USD | -2756.981% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -403.956% |
| Innoviva, Inc. | 255.56 Million USD | 147.4% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -116.841% |
| ESSA Pharma Inc. | -33.62 Million USD | -260.292% |
| GlycoMimetics, Inc. | -40.98 Million USD | -195.566% |
| GT Biopharma, Inc. | -1.02 Million USD | -11764.447% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -78.711% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 297.75% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 9.653% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -774.249% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -319.562% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -160698.577% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -292.509% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1378.195% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -3771.374% |
| Soligenix, Inc. | -4.95 Million USD | -2346.403% |
| Century Therapeutics, Inc. | 847 Thousand USD | 14401.771% |
| Kura Oncology, Inc. | -20.11 Million USD | -502.127% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -195.988% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1342.439% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 6749.631% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -3689.052% |
| Autolus Therapeutics plc | -186.59 Million USD | 35.082% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -145.692% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 56.077% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 453.496% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 173.698% |
| GRI Bio, Inc. | -1.79 Million USD | -6652.285% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1248.496% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -264.242% |
| IGM Biosciences, Inc. | -72.6 Million USD | -66.84% |
| INmune Bio, Inc. | -25.41 Million USD | -376.707% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 180.249% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -139.12% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -645.481% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -4098.929% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 418.653% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -194.127% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 479.915% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 132.051% |
| Verastem, Inc. | -37.27 Million USD | -224.953% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1235.126% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -133.574% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -700.37% |
| Histogen Inc. | -7.48 Million USD | -1517.951% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -460.638% |
| Surrozen, Inc. | -32.66 Million USD | -270.855% |
| Organovo Holdings, Inc. | -1.5 Million USD | -7938.222% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2781.797% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 738.896% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 4730.581% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 3014.726% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1345.339% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -178.845% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -731.016% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 61.761% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -16676.445% |
| Apollomics, Inc. | -27.39 Million USD | -342.183% |
| Amarin Corporation plc | -191.04 Million USD | 36.591% |
| Mesoblast Limited | 55.96 Million USD | 316.457% |
| Turnstone Biologics Corp. | -14.58 Million USD | -730.609% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -378.95% |
| Synaptogenix, Inc. | -28.66 Million USD | -322.644% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -12841.88% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 348.576% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -13951.449% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1567.144% |
| Exelixis, Inc. | -73.05 Million USD | -65.826% |
| Better Therapeutics, Inc. | -860 Thousand USD | -13985.581% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -404.46% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 49.813% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 16557.22% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1528.58% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 9759.968% |
| Gritstone bio, Inc. | 39.49 Million USD | 406.751% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -44.036% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -4502.187% |
| Avid Bioservices, Inc. | 169.72 Million USD | 171.371% |
| Insmed Incorporated | 721.62 Million USD | 116.787% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1225.12% |
| MediWound Ltd. | -5.32 Million USD | -2176.137% |
| OmniAb, Inc. | 9.2 Million USD | 1416.266% |
| Alector, Inc. | -35.63 Million USD | -239.916% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 240.903% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2358.117% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1014.994% |
| Zai Lab Limited | -775 Million USD | 84.37% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 135.57% |
| Aura Biosciences, Inc. | -21.52 Million USD | -462.769% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -46.867% |
| Immunic, Inc. | -45.34 Million USD | -167.172% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 37.305% |
| Veracyte, Inc. | -203.82 Million USD | 40.568% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 118.978% |
| FibroGen, Inc. | 56.76 Million USD | 313.392% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1460.314% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -4184.842% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -5750.997% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.639% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -3525.741% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 27.011% |
| TG Therapeutics, Inc. | 17.86 Million USD | 778.177% |
| Galecto, Inc. | -21.21 Million USD | -470.965% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -409.296% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 107.719% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -394.998% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -952.716% |
| XBiotech Inc. | -200.02 Million USD | 39.439% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -44.036% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 2775.265% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -243.522% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -56.875% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2228.554% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 28.917% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -31.136% |
| Vaxxinity, Inc. | 10.13 Million USD | 1295.578% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 116.453% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1025.01% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -83.662% |
| NexImmune, Inc. | -3.13 Million USD | -3765.661% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -3408.47% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -701.617% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -346.996% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1249.546% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -97139.414% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -198.57% |
| Ainos, Inc. | 4.07 Million USD | 3070.528% |
| Pluri Inc. | 22.82 Million USD | 630.623% |
| Prothena Corporation plc | -608.34 Million USD | 80.088% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -2.004% |
| Celularity Inc. | 65.19 Million USD | 285.82% |
| Rallybio Corporation | -24.1 Million USD | -402.597% |
| Cue Biopharma, Inc. | -33.81 Million USD | -258.189% |
| MeiraGTx Holdings plc | -40.3 Million USD | -200.571% |
| Omeros Corporation | 331.17 Million USD | 136.578% |
| Humacyte, Inc. | -22.48 Million USD | -438.717% |
| Immunocore Holdings plc | -358.59 Million USD | 66.219% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -392.924% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -292.013% |
| Blueprint Medicines Corporation | 702.83 Million USD | 117.235% |
| CalciMedica, Inc. | -5.53 Million USD | -2090.524% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 35.641% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1085.98% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -202.56% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -264.286% |
| Pulmatrix, Inc. | -10.41 Million USD | -1062.868% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -1926.702% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -217.592% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -8.738% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -102.082% |
| Cytokinetics, Incorporated | 642.37 Million USD | 118.858% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -1980.302% |
| Nutriband Inc. | -251.65 Thousand USD | -48035.359% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -255.04% |
| Vor Biopharma Inc. | 4.3 Million USD | 2917.116% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.993% |
| Evogene Ltd. | -19.63 Million USD | -516.971% |
| ProKidney Corp. | -56.23 Million USD | -115.407% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -148.882% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1211.395% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 108.882% |
| CorMedix Inc. | -43.05 Million USD | -181.368% |
| BioLineRx Ltd. | 7.33 Million USD | 1751.254% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -341.056% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 362.5% |
| Atai Life Sciences N.V. | -28.55 Million USD | -324.175% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 5530.819% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -430.926% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 783.034% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -61.355% |
| MediciNova, Inc. | -50.78 Million USD | -138.534% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -53.716% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -538401.889% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1777.324% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 39.378% |
| Biomea Fusion, Inc. | -166.57 Million USD | 27.276% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 32.317% |
| Mereo BioPharma Group plc | -51.46 Million USD | -135.357% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -27.721% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 58.763% |
| Absci Corporation | -72.59 Million USD | -66.859% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2753.0% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 48.329% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -28.579% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -26.584% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -210.025% |
| Allakos Inc. | -24.97 Million USD | -385.029% |
| Imunon, Inc. | -4.21 Million USD | -2774.709% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -721.707% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 10.535% |
| BioAtla, Inc. | -109.01 Million USD | -11.123% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 16557.22% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -12800.532% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1112.335% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -471.315% |
| XOMA Corporation | -29 Million USD | -317.71% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -631.498% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1243.567% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1526.205% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 2.808% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 41.807% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -48.126% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -30.587% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -13998.959% |
| Akari Therapeutics, Plc | -3.84 Million USD | -3050.481% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 7564.215% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 108.772% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -10095.474% |
| UroGen Pharma Ltd. | 4.39 Million USD | 2858.734% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 206.746% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 168433.287% |
| Orgenesis Inc. | 21.78 Million USD | 656.078% |
| Entera Bio Ltd. | -10.62 Million USD | -1039.674% |
| GH Research PLC | -78.07 Million USD | -55.149% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -443.503% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -354.391% |
| Xencor, Inc. | 29.64 Million USD | 508.636% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -6049.622% |
| Replimune Group, Inc. | 1.41 Million USD | 8679.037% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -49361.839% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 4.177% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -10095.474% |
| Portage Biotech Inc. | -4.98 Million USD | -2331.961% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -538401.889% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -83.201% |
| OncoCyte Corporation | -6.56 Million USD | -1745.741% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 13598.356% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2559.032% |
| Purple Biotech Ltd. | -14.13 Million USD | -756.811% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -409.917% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1750.817% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -625.706% |
| HilleVax, Inc. | -165.48 Million USD | 26.799% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -4672.892% |
| Tharimmune, Inc. | -10.93 Million USD | -1007.747% |
| Genprex, Inc. | -6.73 Million USD | -1697.902% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 67.155% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -36.939% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -8546.395% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -3552.034% |
| OKYO Pharma Limited | -826.84 Thousand USD | -14550.335% |
| Savara Inc. | 153 Thousand USD | 79273.856% |
| Curis, Inc. | -23.88 Million USD | -407.121% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2248.548% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -15510.068% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -1851.289% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 10322.447% |
| BeiGene, Ltd. | -2.25 Billion USD | 94.624% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1081.773% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 80.083% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 34.728% |
| Erasca, Inc. | -37.21 Million USD | -225.494% |
| bluebird bio, Inc. | 108.57 Million USD | 211.573% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -9305.75% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 131.983% |
| DBV Technologies S.A. | -126.98 Million USD | 4.607% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -9305.75% |
| Moderna, Inc. | -2.9 Billion USD | 95.833% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1070.17% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1014.612% |
| Molecular Templates, Inc. | 707 Thousand USD | 17233.805% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -286.14% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 134.949% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -47.615% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -32.057% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -275.359% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -252.385% |
| MacroGenics, Inc. | -66.98 Million USD | -80.84% |
| RenovoRx, Inc. | -1.17 Million USD | -10227.025% |
| Adicet Bio, Inc. | -138.78 Million USD | 12.718% |
| Prime Medicine, Inc. | -27.94 Million USD | -333.542% |
| Aditxt, Inc. | 18.12 Million USD | 768.488% |
| Adagene Inc. | -87.62 Million USD | -38.24% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2808.129% |
| Quantum-Si incorporated | -118.55 Million USD | -2.175% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 436.442% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1520.725% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -149.719% |
| SciSparc Ltd. | -2.06 Million USD | -5766.15% |
| Vericel Corporation | 1.27 Million USD | 9585.983% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -910.165% |
| Minerva Neurosciences, Inc. | 41 Million USD | 395.423% |
| Generation Bio Co. | 31.44 Million USD | 485.195% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 30.923% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -291.734% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 203.896% |
| Invivyd, Inc. | -198.47 Million USD | 38.967% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -34.193% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -4952.2% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -71.12% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1674.886% |
| 2seventy bio, Inc. | 181.71 Million USD | 166.663% |
| ADMA Biologics, Inc. | 90.06 Million USD | 234.497% |
| Clene Inc. | 3.34 Million USD | 3726.826% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1233.7% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -463.135% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1777.324% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 64.799% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -365.913% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 168.182% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -2860.626% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 2521.751% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2225.514% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 7.036% |
| Evaxion Biotech A/S | 5.28 Million USD | 2391.272% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -7.611% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 7.722% |
| Trevena, Inc. | 2.25 Million USD | 5464.748% |
| Surrozen, Inc. | -32.66 Million USD | -270.855% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -135.17% |
| Cingulate Inc. | 3.08 Million USD | 4029.564% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -4024.481% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1785.488% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1203.768% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -52.712% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 7.848% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -14.775% |
| Clearmind Medicine Inc. | -3.94 Million USD | -2972.461% |
| Kronos Bio, Inc. | -36.05 Million USD | -235.985% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1387.448% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 8407.644% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -123.267% |
| Statera Biopharma, Inc. | 14.41 Million USD | 940.265% |
| ImmunityBio, Inc. | 618.22 Million USD | 119.594% |
| Korro Bio, Inc. | -132.94 Million USD | 8.881% |
| Kineta, Inc. | -4.54 Million USD | -2567.606% |
| BioVie Inc. | -17.73 Million USD | -583.136% |
| Codexis, Inc. | -43.27 Million USD | -179.947% |
| Celularity Inc. | 65.19 Million USD | 285.82% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -3722.531% |
| Celcuity Inc. | 6.78 Million USD | 1885.742% |
| Virax Biolabs Group Limited | -3.36 Million USD | -3499.941% |
| Cibus, Inc. | -8.07 Million USD | -1399.579% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -2764.412% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 2750.678% |
| IN8bio, Inc. | -16.38 Million USD | -639.13% |
| Kodiak Sciences Inc. | -103.87 Million USD | -16.617% |
| Annexon, Inc. | -193.75 Million USD | 37.48% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 336588.889% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -592.245% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -3348.221% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 111.49% |
| Eyenovia, Inc. | 1.25 Million USD | 9723.882% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 550.236% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3635.307% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -264.352% |
| Arcellx, Inc. | -296.95 Million USD | 59.208% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -521.019% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -105.751% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -484.436% |
| Moolec Science SA | 117.61 Thousand USD | 103092.79% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -215.467% |
| Geron Corporation | 14.76 Million USD | 920.649% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -219.468% |
| Royalty Pharma plc | 5.65 Billion USD | 102.141% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 14.344% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1633.133% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2158.795% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 13.924% |
| Humacyte, Inc. | -22.48 Million USD | -438.717% |
| Structure Therapeutics Inc. | -124.33 Million USD | 2.576% |
| 89bio, Inc. | -289.05 Million USD | 58.092% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -379.899% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -6693.943% |
| Genelux Corporation | -6.89 Million USD | -1655.849% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -290.019% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 244.901% |
| Notable Labs, Ltd. | -9.77 Million USD | -1139.116% |
| Liquidia Corporation | -80.17 Million USD | -51.088% |
| Mustang Bio, Inc. | -3.73 Million USD | -3142.398% |
| Immunovant, Inc. | -635.22 Million USD | 80.93% |
| Quantum-Si incorporated | -118.55 Million USD | -2.175% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -589.683% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -2823.872% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1609.107% |
| Acasti Pharma Inc. | -23 Million USD | -426.564% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -3497.498% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -645.481% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 12.055% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -3787.097% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -444.872% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -552.356% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 28.44% |
| PepGen Inc. | -60.67 Million USD | -99.664% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -427.228% |
| United Therapeutics Corporation | -507.7 Million USD | 76.14% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -533.358% |
| Solid Biosciences Inc. | -47.75 Million USD | -153.688% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -13951.449% |
| Immuneering Corporation | -54.94 Million USD | -120.476% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -2781.797% |
| Silo Pharma, Inc. | -3.52 Million USD | -3337.157% |
| Belite Bio, Inc | -87.27 Million USD | -38.804% |
| XOMA Corporation | -29 Million USD | -317.71% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -71.345% |
| Bionomics Limited | 227 Million USD | 153.362% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -4.174% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -4682.313% |
| uniQure N.V. | -102.95 Million USD | -17.664% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -2808.129% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 395.807% |
| Forte Biosciences, Inc. | -11.96 Million USD | -912.758% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -3814.938% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 114379.245% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3635.307% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1460.314% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1533.441% |
| Altimmune, Inc. | -134.48 Million USD | 9.927% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 161.16% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -4682.313% |
| Compugen Ltd. | -12.9 Million USD | -838.748% |
| Peak Bio, Inc. | 10.34 Million USD | 1271.51% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -42704.24% |
| Benitec Biopharma Inc. | -50.58 Million USD | -139.484% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -16.1% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 716.625% |
| Zura Bio Limited | -99.8 Million USD | -21.371% |
| PolyPid Ltd. | 6.17 Million USD | 2063.306% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 263.432% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 716.625% |
| Instil Bio, Inc. | 75.35 Million USD | 260.747% |
| argenx SE | -2.02 Billion USD | 94.029% |
| Immunome, Inc. | -97.02 Million USD | -24.845% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -438.502% |
| Verona Pharma plc | -220.44 Million USD | 45.049% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -68.847% |
| Shattuck Labs, Inc. | -121.42 Million USD | 0.237% |
| CervoMed Inc. | -7.79 Million USD | -1454.451% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 34.697% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2670.089% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 8.049% |
| Moolec Science SA | 117.61 Thousand USD | 103092.79% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -5194.459% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 861.939% |
| AnaptysBio, Inc. | -18.15 Million USD | -567.379% |
| Design Therapeutics, Inc. | -18.15 Million USD | -567.416% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -72.115% |
| NeurAxis, Inc. | 145.7 Thousand USD | 83240.7% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1178.49% |
| Lumos Pharma, Inc. | -28.49 Million USD | -325.143% |
| Achilles Therapeutics plc | -126.92 Million USD | 4.56% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -68.847% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -18373.457% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -483.118% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 8407.644% |
| Nutriband Inc. | -251.65 Thousand USD | -48035.359% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -819.718% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1528.172% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 135.608% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 610.369% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 72.929% |
| Palisade Bio, Inc. | -12.06 Million USD | -904.195% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 13.666% |
| Beam Therapeutics Inc. | -262.72 Million USD | 53.892% |
| Neurogene Inc. | -131.95 Million USD | 8.199% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 655.262% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2382.295% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 67.885% |
| Sesen Bio, Inc. | -112.55 Million USD | -7.626% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -21.306% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -5059.569% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -210.398% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -45.453% |
| Athira Pharma, Inc. | -88.99 Million USD | -36.109% |
| Vaccinex, Inc. | -1.28 Million USD | -9304.969% |
| HCW Biologics Inc. | 2.85 Million USD | 4340.453% |
| XOMA Corporation | -29 Million USD | -317.71% |
| Nektar Therapeutics | 210.24 Million USD | 157.618% |
| Arvinas, Inc. | -313.8 Million USD | 61.397% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 7564.215% |
| Merus N.V. | -192.88 Million USD | 37.197% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 301.944% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1645.979% |
| Rezolute, Inc. | -68.16 Million USD | -77.702% |
| Clene Inc. | 3.34 Million USD | 3726.826% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -818.602% |
| BeyondSpring Inc. | -13.75 Million USD | -780.669% |
| Synlogic, Inc. | -6.68 Million USD | -1712.057% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 10782.187% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1332.714% |
| Peak Bio, Inc. | 10.34 Million USD | 1271.51% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -46.974% |
| Krystal Biotech, Inc. | -350.23 Million USD | 65.413% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 197.592% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 28.32% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -3736.885% |
| MannKind Corporation | 143.89 Million USD | 184.181% |
| Ikena Oncology, Inc. | -109.15 Million USD | -10.975% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1500.0% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -265.97% |
| Gossamer Bio, Inc. | 180.35 Million USD | 167.165% |
| CohBar, Inc. | -5.93 Million USD | -1942.514% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -307.207% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2753.0% |
| Legend Biotech Corporation | -949.39 Million USD | 87.241% |
| Mural Oncology plc | -255.84 Million USD | 52.652% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 476.024% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -2471.539% |
| Disc Medicine, Inc. | -358.28 Million USD | 66.19% |
| Champions Oncology, Inc. | 4.81 Million USD | 2617.373% |
| REGENXBIO Inc. | 54.76 Million USD | 321.18% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -44947.544% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 19.79% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1244.162% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -50.138% |
| Vaxart, Inc. | -8.24 Million USD | -1369.919% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -141.403% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 4.742% |
| Cellectis S.A. | -43.85 Million USD | -176.219% |
| Longeveron Inc. | -2.9 Million USD | -4065.612% |
| Repare Therapeutics Inc. | -107.85 Million USD | -12.311% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 112.509% |
| Inozyme Pharma, Inc. | 12 Million USD | 1109.13% |
| Revolution Medicines, Inc. | -608.2 Million USD | 80.083% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -9748.455% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 54.308% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 19.281% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -674.18% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -16269.73% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.733% |
| Denali Therapeutics Inc. | -74.86 Million USD | -61.806% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -910.165% |
| Veru Inc. | 4.77 Million USD | 2634.242% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -977.147% |
| Cingulate Inc. | 3.08 Million USD | 4029.564% |
| Passage Bio, Inc. | 4.58 Million USD | 2742.007% |
| Context Therapeutics Inc. | -14.44 Million USD | -738.321% |
| Exicure, Inc. | 5.84 Million USD | 2171.055% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 47.418% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -206.131% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 872.009% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -105.94% |
| Nuvalent, Inc. | -335.38 Million USD | 63.882% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 7084.555% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -62.638% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1262.61% |
| OmniAb, Inc. | 9.2 Million USD | 1416.266% |
| Anew Medical, Inc. | 1.43 Million USD | 8556.472% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 839.457% |
| Lipocine Inc. | -4.75 Million USD | -2447.769% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -10.296% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 895.325% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -139.12% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 586.646% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1702.351% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -84.022% |
| Ocugen, Inc. | -32.52 Million USD | -272.485% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -41.555% |
| Q32 Bio Inc. | -37.94 Million USD | -219.216% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -19189.172% |
| Alumis Inc. Common Stock | -13.52 Million USD | -795.38% |
| Equillium, Inc. | -22.39 Million USD | -440.979% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -373.78% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -271.278% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -48761.908% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 190.372% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 3887.867% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 36982.119% |
| Dominari Holdings Inc. | 195 Thousand USD | 62221.026% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2199.944% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1258.484% |
| Bio-Techne Corporation | 267.74 Million USD | 145.243% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -647.338% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -2.576% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1341.58% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -857.521% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 50.581% |
| Nkarta, Inc. | 57.29 Million USD | 311.41% |
| BioCardia, Inc. | 212 Thousand USD | 57239.623% |
| Iterum Therapeutics plc | 13.43 Million USD | 1001.444% |